GL1X · GenesisL1 explorer

MolNFT v1 · #63912 · protein

Crystal structure of hapten complex of catalytic elimination antibody 13G5 (wild-type)

3FO0 · Catalytic antibody Fab 13G5 kappa light chain chimera: “Crystal structure of hapten complex of catalytic elimination antibody 13G5 (wild-type)”. X-ray diffraction, 1 ligand (BZH), 3 pockets (best druggability 0.67). MolNFT v1 #63912…

PDB
3FO0
Type
protein
Length
430 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Catalytic antibody Fab 13G5 kappa light chain chimera; Catalytic antibody Fab 13G5 IGG2B…
Ligands
BZH
Pockets
3 · best druggability 0.67

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
LCatalytic antibody Fab 13G5 kappa light chain chimeraprotein2165% helix, 52% strand—
HCatalytic antibody Fab 13G5 IGG2B heavy chain chimeraprotein2146% helix, 52% strand—

Ligands and binding sites

  • BZH · 5-[(2-amino-1H-benzimidazol-6-yl)amino]-5-oxopentanoic acid · ligand · chains L, H
  • GOL · Glycerol · additive · chains H

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18040.670.7566empty
2730.590.8920BZH
3990.360.7426empty

Interfaces

1 interface between chains.

  • L–H · 1827 Ų buried · 16 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 3FO0 · Crystal structure of hapten complex of catalytic elimination antibody 13G5 (wild-type) · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.